FBR Capital Markets & Co. Expands Team with Four New Healthcare Analysts and Experienced Investment Banker
October 02 2017 - 4:30PM
FBR Capital Markets & Co. (“FBR”), a leading full service
investment bank and wholly-owned subsidiary of B. Riley Financial,
Inc. (NASDAQ:RILY), announced today that David Buck, George
Zavoico, Ph.D., and Madhu Kumar, Ph.D. have joined the firm as
Equity Research Analysts along with Investment Banker Derrick Li.
B. Riley & Co.’s Senior Analyst Andy D’Silva has also been
added to the team full time to cover healthcare devices and
diagnostics.
FBR and affiliates’ healthcare teams have a successful track
record in the healthcare industry completing over 1751 financings,
including well over 130 ATMs in the industry over the past seven
years. These latest investments support the firm’s effort to expand
and further strengthen its healthcare sector capabilities and
expertise.
“I’m thrilled to have David, Derrick, George, and Madhu join the
FBR team and to have Andy dedicated to medical technology,” said
Patrice McNicoll, Co-Head of FBR’s Investment Banking group. “The
experience these five bring, together with the firm’s existing
network, strengthens our position as a leading investment bank in
the healthcare sector domestically and abroad.”
“B. Riley’s acquisition of FBR earlier this year has expanded
our firm’s expertise and enhanced the level of services we provide
to our clients,” said Bryant Riley, Chairman and CEO of B. Riley
Financial. “Our healthcare-focused service offerings are stronger
than ever. Having these senior level research and banking
professionals join us enhances the value we deliver across our
overall Investment Banking group.” David Buck joins FBR as a Senior
Research Analyst and Senior Vice President with a focus on
specialty and biopharmaceuticals. Previously, Mr. Buck spent 14
years as Senior Vice President of the Buckingham Research Group,
eventually becoming Director, Partner and Equity Analyst, where he
was responsible for the coverage of the specialty pharmaceutical
industry. Buck’s proficiency in public equities will be a catalyst
for coverage growth within FBR’s internal research development.
Dr. George Zavoico joins FBR as a Senior Research Analyst and
Senior Vice President covering biotechnology. He brings over 10
years of equity analyst experience in the financial industry
specializing in biotechnology, biopharmaceutical, specialty
pharmaceutical and molecular diagnostics companies. He is a
two-time recipient of the Financial Times Starmine Award for being
among the top three qualifying Earnings Estimators within the
biotechnology sector. Dr. Zavoico received a B.S. in Biology from
St. Lawrence University and earned a Ph.D. in Physiology from the
University of Virginia.
Dr. Madhu Kumar joins FBR as a Senior Research Analyst and
Senior Vice President covering therapeutics and biopharmaceuticals.
Prior to FBR, Dr. Kumar worked at Chardan LLC with a focus in
disruptive technologies in verticals including small RNA therapies,
RNA therapies, and complement therapies. Previously, he was a
scientific advisor at Wilson Soncini Goodrich & Rosati, where
he drafted both national and international patent applications
related to various technologies in the healthcare sector. Dr. Kumar
graduated with a B.A. in Biochemistry Suma Cum Laude at the
University of Pennsylvania, and received his Ph.D. in Biology at
the Massachusetts Institute of Technology where he notably
developed a lentiviral vector for co-delivery of small RNAs and
gene modification technologies.
Derrick Li joins FBR’s Investment Banking group as Managing
Director specializing in the firm’s healthcare sector. Prior to
joining FBR, Mr. Li was a Co-Founder of TPP Healthcare (“TPP”), a
boutique advisory firm assisting Western healthcare companies build
market access strategies in China. He will lead the evolution of
FBR’s market strategies for China and Southeast Asia, and help
Western parties navigate challenging markets. Mr. Li graduated from
Villanova University with dual degrees in Finance and
Accounting.
About FBR Capital Markets & Co.FBR
Capital Markets & Co., LLC provides investment banking,
M&A advisory, institutional brokerage and research services
with focused capital and financial expertise in consumer, energy
and natural resources, financial institutions, healthcare,
insurance, industrials, real estate, technology, media and telecom
industries.
B. Riley Financial, Inc. is a publicly traded, diversified
financial services company which takes a collaborative approach to
the capital raising and financial advisory needs of public and
private companies and high net worth individuals. The Company
operates through several wholly-owned subsidiaries,
including B. Riley & Co., LLC, FBR Capital
Markets & Co., Wunderlich Securities, Inc., Great
American Group, LLC, B. Riley Capital Management,
LLC (which includes B. Riley Asset Management, B.
Riley Wealth Management, and Great American Capital Partners,
LLC) and B. Riley Principal Investments, a group that makes
proprietary investments in other businesses, such as the
acquisition of United Online, Inc.
1 The following statistic includes all transactions completed by
the Healthcare teams of FBR Capital Markets &Co., its parent B.
Riley Financial, Inc., and affiliate Wunderlich Securities since
September 2012
Media Contact Joe LoBelloLoBello
Communications516-902-2694Joe@LoBelloCommunications.com
B Riley Financial (NASDAQ:RILY)
Historical Stock Chart
From Mar 2024 to Apr 2024
B Riley Financial (NASDAQ:RILY)
Historical Stock Chart
From Apr 2023 to Apr 2024